Hancock Mark has filed a notice to sell 9,024 shares of PACS Group, Inc., valued at approximately $452,120. This filing is significant as it showcases Mark's ongoing involvement with the company and highlights recent trading activity in the skilled nursing care facilities sector.

PACS Group, Inc. operates in the services-skilled nursing care facilities industry. The company is registered in Delaware and has its business address in Salt Lake City, Utah. The recent filing is part of a series of disclosures made by Hancock Mark, who is identified as an officer, director, and a 10% stockholder of the company.

The filing indicates that Hancock Mark's recent transactions include the sale of 144,318 shares on September 14, 2026, and 155,682 shares on September 15, 2026, generating gross proceeds of approximately $6.43 million and $6.61 million, respectively. The shares being sold in the latest filing were acquired at the formation of the issuer on March 1, 2023.

This activity may affect investor sentiment and market dynamics for PACS Group, Inc., as it reflects the financial strategies of key stakeholders in the company. The filing does not specify any future actions or plans following this sale.

The filing also reveals that Hancock Mark acquired a total of 54,626,199 shares at the formation of PACS Group, Inc. on March 1, 2023, with the payment made in cash. This substantial acquisition underscores Mark's significant stake in the company, which is further emphasized by his status as a 10% stockholder.

In addition to the recent sale of shares, the filing notes that Hancock Mark has not reported any sales of securities in the past three months, indicating that the transactions reported were significant in terms of volume and value. The shares being sold in this latest filing are part of the common stock class, which is traded on the NYSE.

The broker facilitating the sale is Citigroup Global Markets Inc., located at 388 Greenwich Street, New York, NY. This partnership may provide insights into the trading strategies and market positioning of Hancock Mark as he navigates his investments in PACS Group, Inc.

Overall, while the filing provides detailed information about recent transactions, it does not include any commentary on the potential impact of these sales on the company's future performance or any strategic initiatives that may be in place following these transactions.